Breaking News
Sort by:
Top Post
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial for the Treatment of Rett Syndrome
Taysha Gene Therapies, a clinical-stage gene therapy company focused on developing and commercializing AAV-based gene […]
Siren Biotechnology Launches to Pioneer Universal AAV Immuno-Gene Therapy™ for Cancer
Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy, a revolutionary new treatment modality for cancer, […]
HuidaGene Therapeutics' Novel DNA Gene-Editing System Cas12i Patent Granted by USPTO
HuidaGene Therapeutics, a clinical-stage company focusing on developing gene editing tools and gene therapies, today […]
Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases
Ray Therapeutics, a leading optogenetics company, today announced an upsized and oversubscribed $100M Series A […]
Malaysian Genomics Inks Expansion Agreement in Bangladesh
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, today announced a strategic […]
Eikonoklastes Announces Formation of Scientific Advisory Board
Eikonoklastes Therapeutics, a biopharmaceutical company developing a novel gene therapy platform to discover and develop […]
SonoThera™ Announces Research Collaboration with Janssen Pharmaceuticals to Accelerate Development of Ultrasound-Guided Nonviral Gene Therapy Platform
SonoThera, a biotechnology company dedicated to treating the root cause of human diseases through genetic […]
Sarepta Therapeutics Announces Positive Vote from FDA Advisory Committee Meeting for SRP-9001 Gene Therapy to Treat Duchenne Muscular Dystrophy
Sarepta Therapeutics, the leader in precision genetic medicine for rare diseases, today announced that the […]
NewBiologix Launches with $50M to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies
NewBiologix SA has launched today as a technology innovation company developing a proprietary and breakthrough platform […]
Synthego Opens State-of-the-Art GMP Guide RNA Manufacturing Facility to Enable CRISPR Genomic Medicines
Synthego, a leading provider of genome engineering solutions, announced today the opening of its state-of-the-art […]
Cellular Origins Partners with ScaleReady to Simplify, Standardise, and Automate Cell Therapy Manufacturing
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective and efficient manufacture of cell […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more